Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4770979

O=C(Nc1ccc2c(c1)CCN(C1CCC1)CC2)c1cc(-c2ccco2)[nH]n1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
POLB P06746 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PIP4K2A P48426 1/20 0.42
LMNA P02545 3/20 0.41
RET P07949 1/20 0.41
SLC2A1 P11166 2/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HRH3 Q9Y5N1 6/20 0.38
MME P08473 1/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
HRH1 P35367 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4793643 0.94 MAPT (0.47) MAPTPOLBMEN1KMT2APIP4K2A
SCHEMBL4771966 0.78 NPC1 (0.40) MAPTPOLBLMNARETSLC2A1
Trifluoroacetic Acid SCHEMBL4775088 0.77 MAP4K1 (0.52)
SCHEMBL4765151 0.77 HRH3 (0.46) NPC1SMN1; SMN2HRH3HRH1
Trifluoroacetic Acid SCHEMBL4765701 0.76 MAPT (0.48) MAPTPOLBMEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL4770760 0.76 HRH3 (0.50) MAPTSLC2A1NPC1SMN1; SMN2HRH3
Trifluoroacetic Acid SCHEMBL4764951 0.75 HRH3 (0.47) MAPTLMNASLC2A1NPC1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4765215 0.75 SMN1; SMN2 (0.47) MAPTSLC2A1NPC1SMN1; SMN2HRH3
Trifluoroacetic Acid SCHEMBL4765505 0.75 SLC2A1 (0.50) MAPTSLC2A1NPC1SMN1; SMN2HRH3
Trifluoroacetic Acid SCHEMBL4768481 0.74 NPY5R (0.49) SLC2A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 MAPT 405/4885POLB 4330/4885MEN1 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.